Ledger.Open graph →
SEC Form D · Amendment · filed June 11, 2014

Carmell Therapeutics Corp

Offering
$1.0M
Sold
$681K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PITTSBURGH, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Stephen Garland · Gardena, CODirectorGus Blass Iii · Gardena, CADirectorDonald Larson · Gardena, CADirectorReginald Greenslade · Gardena, CAExec · DirectorJeffrey Pickett · Kirkwood, MOExec · DirectorJoseph Bayer · Saint Louis, MOExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗